Search results
The Frame Family Foundation Nears $2 Million in Donations for Research, Support, and Treatment of...
PRWeb· 21 hours agoErdheim-Chester disease is a multi-system disorder that impacts approximately 2,000 people worldwide. Current treatments target mutations in the MAPK pathway ...
EHA 2024 | Results from Five Studies of Ascentage Pharma's Key Drug Candidates Selected for...
WTNH-TV New Haven· 12 hours agoAscentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced ...
Abortion bans made Minnesota a health care island. Could the same happen with IVF?
Medical Xpress· 1 hour agoMeta Getman and her husband had spent more than three years struggling with infertility—including...
The Assistance Fund Opens New Program for Chronic Obstructive Pulmonary Disease
Digital Journal· 3 days agoFund, or for information on how to donate, please visit tafcares.org... margaret.figley@tafcares.org [1] Mayo Clinic, "Chronic Obstructive ...
Profound Medical Corp. (NASDAQ:PROF) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 days agoProfound Medical Corp. (NASDAQ:PROF) Q1 2024 Earnings Call Transcript May 11, 2024 Profound Medical...
Clinicians Call for Easing FDA Warnings on Low-Dose Estrogen
Medscape· 2 days agoCharles Powell, MD, said he sometimes has a hard time persuading patients to start on low-dose...
Michael Smolens: Unshackling research on guns, marijuana
U-T San Diego· 1 day agoThe 9th U.S. Circuit Court of Appeals upheld a San Diego federal judge’s dismissal of a lawsuit...
No need to fear menopause hormone drugs, major health study suggests
U-T San Diego· 2 days agoThe new research found that for many younger menopausal women — typically those under 60 — the benefits of the drugs probably outweigh the risks for the short-term treatment
Lawn sprinklers expose Utah kids to water contaminated with E. coli
UPI· 6 days agoHappily jumping around lawn sprinklers on a hot summer day: An idyllic childhood scene. Not so for...
Sumitomo Pharma Announces FDA Acceptance of Supplemental New Drug Application for Vibegron in Men...
WKRN Nashville· 3 days agoIf approved, vibegron will be the first and only beta-3 agonist for the treatment of men with OAB symptoms receiving pharmacological therapy for BPH...